Private placement in EXACT Therapeutics AS (NO) and subsequent admittance for trading on Euronext Growth Oslo — NOK 155 million

Carnegie acted as sole manager and bookrunner in the private placement of 29,804 shares at a subscription price of NOK 5,201 per share and as Merkur advisor in the subsequent admittance of the company’s shares for trading on the Merkur Market. EXACT-Tx is a clinical stage Norwegian biotech company developing a technology platform for targeted therapeutic enhancement – Acoustic Cluster Therapy (ACT®). July 2020.